Effects of Obesity, Blood Pressure, and Blood Metabolic Biomarkers on Grey Matter Brain Healthcare Quotient: A Large Cohort Study of a Magnetic Resonance Imaging Brain Screening System in Japan

This study investigated the relationship between grey matter (GM) volume and blood biomarkers, blood pressure, and obesity. We aimed to elucidate lifestyle factors that promote GM volume loss. A total of 1799 participants underwent the brain dock as a medical checkup. Data regarding blood pressure,...

Full description

Bibliographic Details
Main Authors: Keita Watanabe, Shingo Kakeda, Kiyotaka Nemoto, Keiichi Onoda, Shuhei Yamaguchi, Shotai Kobayashi, Yoshinori Yamakawa
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/11/11/2973
_version_ 1797492949357953024
author Keita Watanabe
Shingo Kakeda
Kiyotaka Nemoto
Keiichi Onoda
Shuhei Yamaguchi
Shotai Kobayashi
Yoshinori Yamakawa
author_facet Keita Watanabe
Shingo Kakeda
Kiyotaka Nemoto
Keiichi Onoda
Shuhei Yamaguchi
Shotai Kobayashi
Yoshinori Yamakawa
author_sort Keita Watanabe
collection DOAJ
description This study investigated the relationship between grey matter (GM) volume and blood biomarkers, blood pressure, and obesity. We aimed to elucidate lifestyle factors that promote GM volume loss. A total of 1799 participants underwent the brain dock as a medical checkup. Data regarding blood pressure, obesity measurements, and standard blood biomarkers were obtained. Further, brain magnetic resonance imaging (MRI), including high-resolution T1-weighted imaging, was performed. We calculated the grey matter brain healthcare quotient (GM-BHQ), which represents GM volume as a deviation value. After adjusting for confounding variables, multiple regression analysis revealed that body mass index (BMI) (<i>b</i> = −0.28, <i>p</i> < 0.001), gamma-glutamyltransferase (γ-GTP) (<i>b</i> = −0.01, <i>p</i> = 0.16), and fasting blood glucose (<i>b</i> = −0.02, <i>p</i> = 0.049) were significantly correlated with GM-BHQ. Although the current cross-sectional study cannot determine a cause-and-effect relationship, elevated BMI, γ-GTP, and fasting blood glucose could promote GM volume loss.
first_indexed 2024-03-10T01:12:58Z
format Article
id doaj.art-2887123a80d143238dfcb301b47bd530
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-10T01:12:58Z
publishDate 2022-05-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-2887123a80d143238dfcb301b47bd5302023-11-23T14:14:39ZengMDPI AGJournal of Clinical Medicine2077-03832022-05-011111297310.3390/jcm11112973Effects of Obesity, Blood Pressure, and Blood Metabolic Biomarkers on Grey Matter Brain Healthcare Quotient: A Large Cohort Study of a Magnetic Resonance Imaging Brain Screening System in JapanKeita Watanabe0Shingo Kakeda1Kiyotaka Nemoto2Keiichi Onoda3Shuhei Yamaguchi4Shotai Kobayashi5Yoshinori Yamakawa6Institution of Open Innovation, Kyoto University, Kyoto 606-8501, JapanDepartment of Diagnostic Radiology, Hirosaki University Graduate School of Medicine Radiology, Aomori 036-8562, JapanDivision of Clinical Medicine, Department of Neuropsychiatry, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8577, JapanDepartment of Psychology, Otemon Gakuin University, Osaka 567-8502, JapanDepartment of Neurology, Shimane University, Izumo 690-0823, JapanDepartment of Neurology, Shimane University, Izumo 690-0823, JapanInstitution of Open Innovation, Kyoto University, Kyoto 606-8501, JapanThis study investigated the relationship between grey matter (GM) volume and blood biomarkers, blood pressure, and obesity. We aimed to elucidate lifestyle factors that promote GM volume loss. A total of 1799 participants underwent the brain dock as a medical checkup. Data regarding blood pressure, obesity measurements, and standard blood biomarkers were obtained. Further, brain magnetic resonance imaging (MRI), including high-resolution T1-weighted imaging, was performed. We calculated the grey matter brain healthcare quotient (GM-BHQ), which represents GM volume as a deviation value. After adjusting for confounding variables, multiple regression analysis revealed that body mass index (BMI) (<i>b</i> = −0.28, <i>p</i> < 0.001), gamma-glutamyltransferase (γ-GTP) (<i>b</i> = −0.01, <i>p</i> = 0.16), and fasting blood glucose (<i>b</i> = −0.02, <i>p</i> = 0.049) were significantly correlated with GM-BHQ. Although the current cross-sectional study cannot determine a cause-and-effect relationship, elevated BMI, γ-GTP, and fasting blood glucose could promote GM volume loss.https://www.mdpi.com/2077-0383/11/11/2973MRIGM-BHQGM volumeBMIblood biomarkerblood pressure
spellingShingle Keita Watanabe
Shingo Kakeda
Kiyotaka Nemoto
Keiichi Onoda
Shuhei Yamaguchi
Shotai Kobayashi
Yoshinori Yamakawa
Effects of Obesity, Blood Pressure, and Blood Metabolic Biomarkers on Grey Matter Brain Healthcare Quotient: A Large Cohort Study of a Magnetic Resonance Imaging Brain Screening System in Japan
Journal of Clinical Medicine
MRI
GM-BHQ
GM volume
BMI
blood biomarker
blood pressure
title Effects of Obesity, Blood Pressure, and Blood Metabolic Biomarkers on Grey Matter Brain Healthcare Quotient: A Large Cohort Study of a Magnetic Resonance Imaging Brain Screening System in Japan
title_full Effects of Obesity, Blood Pressure, and Blood Metabolic Biomarkers on Grey Matter Brain Healthcare Quotient: A Large Cohort Study of a Magnetic Resonance Imaging Brain Screening System in Japan
title_fullStr Effects of Obesity, Blood Pressure, and Blood Metabolic Biomarkers on Grey Matter Brain Healthcare Quotient: A Large Cohort Study of a Magnetic Resonance Imaging Brain Screening System in Japan
title_full_unstemmed Effects of Obesity, Blood Pressure, and Blood Metabolic Biomarkers on Grey Matter Brain Healthcare Quotient: A Large Cohort Study of a Magnetic Resonance Imaging Brain Screening System in Japan
title_short Effects of Obesity, Blood Pressure, and Blood Metabolic Biomarkers on Grey Matter Brain Healthcare Quotient: A Large Cohort Study of a Magnetic Resonance Imaging Brain Screening System in Japan
title_sort effects of obesity blood pressure and blood metabolic biomarkers on grey matter brain healthcare quotient a large cohort study of a magnetic resonance imaging brain screening system in japan
topic MRI
GM-BHQ
GM volume
BMI
blood biomarker
blood pressure
url https://www.mdpi.com/2077-0383/11/11/2973
work_keys_str_mv AT keitawatanabe effectsofobesitybloodpressureandbloodmetabolicbiomarkersongreymatterbrainhealthcarequotientalargecohortstudyofamagneticresonanceimagingbrainscreeningsysteminjapan
AT shingokakeda effectsofobesitybloodpressureandbloodmetabolicbiomarkersongreymatterbrainhealthcarequotientalargecohortstudyofamagneticresonanceimagingbrainscreeningsysteminjapan
AT kiyotakanemoto effectsofobesitybloodpressureandbloodmetabolicbiomarkersongreymatterbrainhealthcarequotientalargecohortstudyofamagneticresonanceimagingbrainscreeningsysteminjapan
AT keiichionoda effectsofobesitybloodpressureandbloodmetabolicbiomarkersongreymatterbrainhealthcarequotientalargecohortstudyofamagneticresonanceimagingbrainscreeningsysteminjapan
AT shuheiyamaguchi effectsofobesitybloodpressureandbloodmetabolicbiomarkersongreymatterbrainhealthcarequotientalargecohortstudyofamagneticresonanceimagingbrainscreeningsysteminjapan
AT shotaikobayashi effectsofobesitybloodpressureandbloodmetabolicbiomarkersongreymatterbrainhealthcarequotientalargecohortstudyofamagneticresonanceimagingbrainscreeningsysteminjapan
AT yoshinoriyamakawa effectsofobesitybloodpressureandbloodmetabolicbiomarkersongreymatterbrainhealthcarequotientalargecohortstudyofamagneticresonanceimagingbrainscreeningsysteminjapan